Celgene Palidomide: CC-4047-BRN-001: A Phase 2 Clinical Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults with Recurrent or Progressive Primary Brain Tumors

      Project: Research project

      Project Details

      StatusActive
      Effective start/end date6/28/178/31/50

      Funding

      • Celgene Corporation
      • Celgene Corporation